Pharmaceuticals Headlines from PR Newswire

< Go Back

Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality
PHT Corporation Achieves 125% Increase in Demand for Patient-Driven eData Systems in 1st Quarter 2014
Questcor Partners with National Kidney Foundation as National Sponsor of Kidney Walk
Pharmaceutical Excipients Market by Products & Functionality - Global Forecast to 2018
Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia
Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU
Columbia Laboratories to Discuss First Quarter 2014 Financial Results on April 29th Conference Call
Heart Metabolics Limited Launched in Ireland with $20 Million Series A Financing
JCM Updates on Azithromycin API Export
Hagens Berman: Galena Biopharma Investigation Proceeds in Light of May 5, 2014 Lead Plaintiff Deadline in Securities Fraud Class Actions
Nanotechnology in Drug Delivery
Alexza to Report 2014 First Quarter Financial Results on Monday, May 5, 2014
Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides & Phenicols, & Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 201
Mylan Launches First Generic ORTHO EVRA® Patch
SI Group to Acquire Antioxidants, Ibuprofen and Propofol Businesses from Albemarle Spanish Portuguese
Cerilliant Introduces New Certified Snap-N-Spike® Solutions of Corticosteroids
Astellas Pharma US, Inc. reaches agreement with U.S. Department of Justice
UniFirst's Prestige Packaging Helps Keep Everyday Healthcare Costs in Check
Application Now Open for Students with Cystic Fibrosis for the 2014 AbbVie CF Scholarship
ePharmaSolutions' ReferralPlus™ Increases Match Rate For Clinical Trial Volunteers By More than 66% During Pilot Studies With Major Pharmaceutical Consortium Members
Ending Neostigmine Methylsulfate Injection Shortages With BLOXIVERZ®, The Only FDA-Approved Neostigmine Methylsulfate Injection
A Natural Step For Peptide Research
Sinovac Files 2013 Annual Report on Form 20-F
Impax Launches Authorized Generic RENVELA®
U.S. Congressman Compares Corruption in CDC's Vaccine Safety Studies to SEC's Handling of Bernie Madoff Scandal
AMRI Realigns Discovery and Development Services to Support Customer Demand Portuguese
Medbox, Inc. Announces Creation of a Shareholder Due Diligence Q&A Section on the Company's Website
Rapid Fire Marketing Files 10K with U.S. Securities and Exchange Commission
Global Hypertension Drugs Market 2014-2018
Iconic Therapeutics Raises $20 Million to Advance Clinical Development of Wet AMD Program
Nexvet Announces US$31.5 Million Financing
UC Irvine Health Provides the Only Pediatric Pain Doctor in Southern California Treating Chronic Pain in Children
Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas
Kolltan Pharmaceuticals Expands Company's Board of Directors
Physicians Interactive's Transformative Omnio Medical App Expands from iPad to iPhone, Android Versions
Abbott Reports First-Quarter 2014 Results
Pharmaceutical Market: Greece, Denmark, Bahrain, Sri Lanka, Czech Republic by
Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019
OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs
Heptares at Upcoming Diabetes and Neuroscience Partnering and Investment Conferences
Wilson Therapeutics Secures $40 Million Private Financing To Advance Late Stage Development Program For Wilson's Disease Portuguese
Phase 2a Clinical Study Data of AJM300, Oral alpha 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014
BioMed Realty Earns Upgraded Investment Grade Corporate Credit Rating From Standard & Poor's Ratings Services
Endo to Announce First Quarter 2014 Financial Results on May 1, 2014
Adamas Pharmaceuticals Announces Closing of Its Initial Public Offering
Zogenix Announces Ruling Preventing the Implementation of Massachusetts Governor's Order that Prevented Access to Zohydro™ ER
EPDI Announces Promotion of Beier to Laboratory Manager
GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide) English
XBiotech Welcomes Addition of Senior Vice President Corporate Development & General Counsel
Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine

< Prev Next >
PR Newswire - United Business Media